Stay updated on AcSé: Rare Cancer Types Access Clinical Trial
Sign up to get notified when there's something new on the AcSé: Rare Cancer Types Access Clinical Trial page.

Latest updates to the AcSé: Rare Cancer Types Access Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference3%
- Check25 days agoChange DetectedCore content updated: standardized medical naming and version tag from v3.0.2 to v3.1.0; old phrasing removed and replaced with formalized nomenclature.SummaryDifference0.2%
- Check40 days agoChange DetectedThe page revision was updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed as part of the update.SummaryDifference0.2%
- Check47 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check54 days agoChange DetectedThe web page has been updated to include new facility and location information, as well as recent publications related to pembrolizumab and various types of lymphoma and sarcoma. Notably, some previously listed resources and terms have been removed, including certain cancer types and the previous version number.SummaryDifference8%
- Check61 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.8%
Stay in the know with updates to AcSé: Rare Cancer Types Access Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AcSé: Rare Cancer Types Access Clinical Trial page.